Singapore markets closed

ProKidney Corp. (PROK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.0550+0.2650 (+6.99%)
At close: 04:00PM EDT
4.1500 +0.10 (+2.34%)
After hours: 07:22PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 242.27M
Enterprise value -80.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)91.32
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.76

Trading information

Stock price history

Beta (5Y monthly) 1.11
52-week change 3-58.80%
S&P500 52-week change 326.36%
52-week high 313.5100
52-week low 31.1200
50-day moving average 32.0470
200-day moving average 33.3193

Share statistics

Avg vol (3-month) 3778.24k
Avg vol (10-day) 3755.55k
Shares outstanding 563.92M
Implied shares outstanding 6173.38M
Float 845.85M
% held by insiders 16.45%
% held by institutions 151.97%
Shares short (30 Apr 2024) 410.29M
Short ratio (30 Apr 2024) 49.31
Short % of float (30 Apr 2024) 419.45%
Short % of shares outstanding (30 Apr 2024) 416.10%
Shares short (prior month 28 Mar 2024) 413.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-21.34%
Return on equity (ttm)-31.72%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -146.6M
Net income avi to common (ttm)-35.3M
Diluted EPS (ttm)-0.5700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)329M
Total cash per share (mrq)5.15
Total debt (mrq)5.95M
Total debt/equity (mrq)1.64%
Current ratio (mrq)17.62
Book value per share (mrq)-17.79

Cash flow statement

Operating cash flow (ttm)-98.72M
Levered free cash flow (ttm)-85.9M